Medscape
The recent US Food and Drug Administration (FDA) clearance of two over-the-counter (OTC) continuous glucose monitors (CGMs) — Dexcom’s Stelo and Abbott’s Lingo — has sparked interest in potentially expanding their use to those without diabetes or prediabetes. There are several valid questions about how the general population might benefit from CGMs…
Read More
Continuous Glucose Monitors for All? Opinions Remain Mixed
Stephania Culton
14:20
The recent US Food and Drug Administration (FDA) clearance of two over-the-counter (OTC) continuous glucose monitors (CGMs) — Dexcom’s Stelo and Abbott’s Lingo — has sparked interest in potentially expanding their use to those without diabetes or prediabetes. There are several valid questions about how the general population might benefit from CGMs…
